Pharma Journalist -

U.S FDA has granted 510 (k) clearance to Bio-Rad Laboratories for the IH-Incubator L and IH-Centrifuge L instruments to be used with the full range of Bio-Rad’s IH-System Gel Reagents…
Read More...

Enzychem Lifesciences Corp asserted that the US Food and Drug Administration has granted Orphan Drug Designation to EC-18 for treating Acute Radiation Syndrome. US FDA Orphan Drug…
Read More...

Astellas Pharma and Vical asserted the negative results for Phase 3 Helios Clinical Trial for ASP0113, an investigational DNA vaccine being developed for cytomegalovirus…
Read More...

Boston-based Biopharmaceutical company, BERG proclaimed that the U.SS FDA has extended orphan-drug designation to the Company's leading product candidate BPM31510, for the treatment of…
Read More...

Immuno-oncology company, Agenus asserted the launch of its proprietary anti- CTLA4 (AGEN1884) and anti-PD1 (AGEN2034) antibodies. The open-label Phase 1/2 study is designed to evaluate…
Read More...

Clinical stage Biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary diseases, Pulmatrix sought approval of its Clinical Trial Application from…
Read More...

Amgen affirms optimistic outcomes for Phase 3b LIBERTY study evaluating the efficacy and safety of Aimovig (erenumab) 140 mg in patients with episodic migraine who had experienced two…
Read More...

SMi’s global panel of speakers will strengthen your knowledge in key topics such as high potent ingredients, ADC payloads, PK-PD technological advancements, warheads and site…
Read More...

Medrobotics Corporation asserted that FDA has granted clearance to promulgate the Flex Robotics System for robot-assisted visualization in general surgical, gynecological and thoracic…
Read More...

AstraZeneca and Merck asserted the sanctioning of LYNPARZA tablets for patients with platinum-sensitive relapsed ovarian cancer, regardless of their BRCA mutation status, who responded…
Read More...